Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric S Lander

Showing results (231-240 of 347) with videos related to

Pageof 35
Sort By:
Plos Biology|December 18, 2009
ZBED6, a novel transcription factor derived from a domesticated DNA transposon regulates IGF2 expression and muscle growthEllen Markljung, Lin Jiang, Jacob D Jaffe, et al.
The New England Journal of Medicine|November 27, 2014
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequenceGiulio Genovese, Anna K Kähler, Robert E Handsaker, et al.
Cell|May 14, 2013
Transcriptional and epigenetic dynamics during specification of human embryonic stem cellsCasey A Gifford, Michael J Ziller, Hongcang Gu, et al.
Cell|February 19, 2013
Evolution and impact of subclonal mutations in chronic lymphocytic leukemiaDan A Landau, Scott L Carter, Petar Stojanov, et al.
Molecular Cancer|June 5, 2014
Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximabJeonghee Cho, Adam J Bass, Michael S Lawrence, et al.
Cell|October 7, 2017
Cohesin Loss Eliminates All Loop DomainsSuhas S P Rao, Su-Chen Huang, Brian Glenn St Hilaire, et al.
Nature Genetics|July 21, 2015
Paired exome analysis of Barrett's esophagus and adenocarcinomaMatthew D Stachler, Amaro Taylor-Weiner, Shouyong Peng, et al.
Genome Research|February 25, 2010
Integrative analysis of the melanoma transcriptomeMichael F Berger, Joshua Z Levin, Krishna Vijayendran, et al.
Genome Research|February 5, 2015
Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolutionHoon Kim, Siyuan Zheng, Seyed S Amini, et al.
Cancer Discovery|March 15, 2014
Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanibNikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, et al.
Pageof 35

Showing results (231-240 of 347) with videos related to

Sort By:
Pageof 35
Plos Biology|December 18, 2009
ZBED6, a novel transcription factor derived from a domesticated DNA transposon regulates IGF2 expression and muscle growthEllen Markljung, Lin Jiang, Jacob D Jaffe, et al.
The New England Journal of Medicine|November 27, 2014
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequenceGiulio Genovese, Anna K Kähler, Robert E Handsaker, et al.
Cell|May 14, 2013
Transcriptional and epigenetic dynamics during specification of human embryonic stem cellsCasey A Gifford, Michael J Ziller, Hongcang Gu, et al.
Cell|February 19, 2013
Evolution and impact of subclonal mutations in chronic lymphocytic leukemiaDan A Landau, Scott L Carter, Petar Stojanov, et al.
Molecular Cancer|June 5, 2014
Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximabJeonghee Cho, Adam J Bass, Michael S Lawrence, et al.
Cell|October 7, 2017
Cohesin Loss Eliminates All Loop DomainsSuhas S P Rao, Su-Chen Huang, Brian Glenn St Hilaire, et al.
Nature Genetics|July 21, 2015
Paired exome analysis of Barrett's esophagus and adenocarcinomaMatthew D Stachler, Amaro Taylor-Weiner, Shouyong Peng, et al.
Genome Research|February 25, 2010
Integrative analysis of the melanoma transcriptomeMichael F Berger, Joshua Z Levin, Krishna Vijayendran, et al.
Genome Research|February 5, 2015
Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolutionHoon Kim, Siyuan Zheng, Seyed S Amini, et al.
Cancer Discovery|March 15, 2014
Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanibNikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, et al.
Pageof 35